While gene mutations have not been detected in human cancers5, CDC42 has been reported to be overexpressed in several types of human cancers including colorectal adenocarcinoma6, breast cancer7, testicular cancer8 and non-small cell lung cancer9. This evidence concerns the gene CDC42 and cancer.